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Abstract
Background: Generalized anxiety disorder (GAD) is a psychiatric disorder characterized by a
constant and unspecific anxiety that interferes with daily-life activities. Its high prevalence in general
population and the severe limitations it causes, point out the necessity to find new efficient
strategies to treat it. Together with the cognitive-behavioural treatments, relaxation represents a
useful approach for the treatment of GAD, but it has the limitation that it is hard to be learned. To
overcome this limitation we propose the use of virtual reality (VR) to facilitate the relaxation
process by visually presenting key relaxing images to the subjects. The visual presentation of a
virtual calm scenario can facilitate patients' practice and mastery of relaxation, making the
experience more vivid and real than the one that most subjects can create using their own
imagination and memory, and triggering a broad empowerment process within the experience
induced by a high sense of presence.
According to these premises, the aim of the present study is to investigate the advantages of using
a VR-based relaxation protocol in reducing anxiety in patients affected by GAD.
Methods/Design: The trial is based on a randomized controlled study, including three groups of
25 patients each (for a total of 75 patients): (1) the VR group, (2) the non-VR group and (3) the
waiting list (WL) group. Patients in the VR group will be taught to relax using a VR relaxing
environment and audio-visual mobile narratives; patients in the non-VR group will be taught to
relax using the same relaxing narratives proposed to the VR group, but without the VR support,
and patients in the WL group will not receive any kind of relaxation training. Psychometric and
psychophysiological outcomes will serve as quantitative dependent variables, while subjective
reports of participants will be used as qualitative dependent variables.
Conclusion: We argue that the use of VR for relaxation represents a promising approach in the
treatment of GAD since it enhances the quality of the relaxing experience through the elicitation
of the sense of presence. This controlled trial will be able to evaluate the effects of the use of VR
in relaxation while preserving the benefits of randomization to reduce bias.
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Background
According to the DSM-IV-TR [1] the essential features of
generalized anxiety disorder (GAD) are an excessive anxi-
ety and an uncontrollable worry (apprehensive expecta-
tion), occurring more days than not for a period of at least
6 months, about a number of events or activities. Anxiety
and worry are often accompanied by additional symp-
toms like restlessness, being easily fatigued, difficulty con-
centrating, irritability, muscle tension, and disturbed
sleep. Although individuals with GAD may not always
identify their worries as "excessive," they report subjective
distress due to constant worry, have difficulty in control-
ling it, or experience related impairment in social, occupa-
tional, or other important areas of functioning. During
the course of the disorder, the focus of worry may shift
from one concern to another. Intensity, duration, or fre-
quency of anxiety and worry are far out of proportion to
the actual likelihood or impact of the feared event. Differ-
ently from other anxiety disorders usually associated to
specific stimuli or situations, GAD is characterized by a
constant and unspecific anxiety, involving a process of
interacting systems (attentional, conceptual, imaginal,
physiological, affective, and behavioural) that unfold over
time in continual response to a constantly changing envi-
ronment.
A quite recent study affirms that the prevalence of GAD in
the general population might actually be as high as 5 to
8% [2], while among individuals seeing their physicians
for psychological problems the 25% of them have a diag-
nosis of pure GAD. Indeed, in primary care facilities, GAD
is the most frequent anxiety disorder and the second most
frequent of all mental disorders [3,4]. GAD is more prev-
alent in women and much more prevalent in youths,
where 12% to 20% are affected [5-7]. The age of onset is
between the late teens and early twenties and the average
duration is about 20 years, suggesting a chronic and fluc-
tuating course that often worsens during time of stress.
People with general nervousness, depression, inability to
tolerate frustration, and feelings of being inhibited are
more likely to be shown in GAD patients. People with
GAD tend to have more conflicts with others, are very
hard on themselves, and tend to avoid common situa-
tions for fear of worry and anxiety. In youths, GAD often
leads to lower levels of social supports, academic undera-
chievement, underemployment, substance use and high
probability of developing other psychiatric disorders. In
epidemiological studies of GAD a consistent finding has
been that over 90% of individuals who meet criteria for
GAD in a given year will also have at least one other DSM-
IV diagnosis [8].
The high prevalence of GAD in the general population
and the severe limitation it causes, point out the necessity
to find new strategies to treat it in a more efficient way.
GAD is usually treated with medications and/or psycho-
therapy. In particular, the two most promising treatments
seem to be cognitive therapy and applied relaxation. As
shown by numerous studies, both of these treatments are
equally effective [9,10] immediately and over long-term
periods. Cognitive treatment helps patients to recognize
and alter patterns of distorted thinking and dysfunctional
behaviour, while relaxation serves to reduce the increased
physical arousal often strictly associated to this disorder.
In fact, physical arousal can be voluntarily altered with
training in relaxation skills that enables patients to shift
physical functions voluntarily toward those that naturally
occur in a relaxed state [11]. Progressive muscle relaxation
and more general imagery techniques can be used as ther-
apy progresses since the ability to relax, and to do it in any
place or situation, is vital to reduce the anxiety level.
Even if relaxation represents a useful approach for the
treatment of GAD, it presents an important limitation: it
is difficult to be learned. Traditionally, relaxation tech-
niques are verbally taught by a therapist or recorded on an
audiotape, while recently a series of CDs of calming music
have been used to help individuals to relax themselves,
showing positive effects on anxiety reduction by achieving
psychological benefits including distraction and sense of
control over symptoms. Music interventions also have
reported good results to reduce state and trait anxiety, to
ease stress, and to increase relaxation [12-14]. These CDs
strengthened the positive effect of calm and sedative
music with relaxation techniques to achieve enhanced
effects. To increase effectiveness, commercial relaxation
DVDs have also integrated visual stimuli. In such a deliv-
ery, the visual representation of the scenario supports the
process of relaxation creating an isolated context in which
the subject can feel to stay.
Virtual reality (VR) can also be used to facilitate relaxation
processes in stressed or anxious subjects [15] by visually
presenting key relaxing images [16]. The advantage of VR
compared to CDs or DVDs is its ability to induce a sense
of presence in the users, that is defined as the "feeling of
being in a world that exists outside of the self " [17]. The
visual presentation of a virtual calm scenario can facilitate
patients' practice and mastery of relaxation, making the
experience more vivid and real than the one that most
subjects can create using their own imagination and mem-
ory, and triggering a broad empowerment process within
the experience induced by a high sense of presence. VR
can be provided using desktops or laptops connected to a
variety of peripheral devices, such as head-mounted dis-
plays and joysticks and even trough different kinds of
mobile devices, such as the new generation of portable
audio-visual devices, cellular phones and hand-held per-
sonal digital assistants (PDAs) equipped with enough raw
horse power to deliver a good 3D experience.Trials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
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Aim of the study
Knowing that relaxation techniques are as effective as cog-
nitive and behavioural methods in the treatment of GAD
and considering the critical point regarding the difficult in
learning them, the aim of the present study is to investi-
gate the advantages of using a VR-based relaxation proto-
col in reducing anxiety in patients affected by GAD. The
following hypothesis will be tested:
I) GAD patients exposed to a VR relaxing environment
learn how to relax themselves easier and more efficiently
than patients exposed to a traditional relaxation protocol;
II) There is a positive correlation between the treatment
efficacy and the sense of presence experienced by the
patients during the treatment sessions.
3-D audio-visual experiences, whose critical aspect is to
induce a feeling of presence and engagement, will be pre-
sented to the subjects in order to help them to become
relaxed. Through the link between the feeling of presence
and the emotional state, VR relaxing environments will be
used to reduce the anxiety levels in their users [15].
Methods
The present trial is based on a randomized controlled
study, including three groups of patients: (1) the VR
group, (2) the non-VR group and (3) the waiting list (WL)
group. Patients diagnosed with GAD according to the
DSM-IV criteria, will be randomly assigned to one of these
three groups.
Subjects
Patients will be recruited in a public health-care structure
in Milan, Italy, according to the diagnosis received from
their treating responsible psychiatrist or psychologist. In
order to be included in the study, patients have to meet
the following criteria: (1) primary diagnosis of GAD; (2)
requesting treatment for their GAD; (3) older than 17 and
younger than 70; (4) no depressive disorder preceding the
current episode of GAD or requiring immediate treat-
ment; (5) no behaviour therapy received for their GAD;
(6) no evidence of organic mental disorders accounting
for the complaints, mental retardation, psychotic disor-
ders, alcohol or drug dependence; (7) no migraine, head-
ache, seizure disorder, and vestibular abnormalities since
they represent significant contraindications for the use of
VR.
A power analysis was conducted in order to evaluate the
number of patients needed to detect a significant differ-
ence (Effect size f ≥ 0,40) between the three groups (VR,
non VR and WL) with a power of 0,90. The analysis
showed a necessary total sample size of 75, 25 in each
group, with α = 0,5, two-tailed. Both males and females
will be included. All participants have to be clinically sta-
ble, meaning no change in dose of psychotropic medica-
tions 1 month before inclusion. Since over 90% of
individuals who meet criteria for GAD in a given year will
also have at least one other DSM-IV diagnosis [8], patients
will be included in the study even if they present at least
one more psychiatric diagnosis.
Before participating in the study, each patient will be pro-
vided with written information about the study and
invited to give written consent for inclusion. The present
research is in compliance with the Helsinki Declaration.
Withdrawal from the study
A patient must be withdrawn form the study when judged
necessary by the responsible of the protocol or when the
patient withdraws his/her informed consent.
Clinical assessment
Subjects will be assessed by independent clinicians who
will not be involved in the direct clinical care of any of
them. They will be psychiatrists, MA-level chartered psy-
chologists or PhD-level chartered psychotherapists. A
semistructured interview will be used with the aim of
identifying relevant DSM-IV diagnostic criteria for GAD in
the subjects.
Psychometric assessment
The following psychometric questionnaires will be
administered to each patient at pre-treatment, upon com-
pletion of the clinical trial, and after 6-month and 12-
month follow-up periods:
- PSWQ – Penn State Worry Questionnaire – [18]. The
PSWQ is the only existing questionnaire specific for GAD
with an extensive validation on Italian population. It ana-
lyzes symptoms of pathological worries that characterize
this disorder.
- BAI – Beck Anxiety Inventory – [19]. The BAI is a stand-
ardised and well-used assessment measure with good psy-
chometric properties used to assess anxiety. It is a 21-item
scale which covers cognitive, behavioural and physiologi-
cal symptoms of anxiety.
- Anti – Anxious Thoughts Inventory – [20]. The AnTI
included 22 items that investigate 3 different categories of
worries: social worries, worries linked to health and the
metacognitions about worry (fear of fear). The available
data show that the AnTI questionnaire is sensitive to treat-
ment effects.
- CID – Anxiety and Depression Scales of the Clinical
Interview for Depression – [21]. The CID anxiety scaleTrials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
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consists of 4 items rated on a 7-point scale. The CID
depression scale includes 10 items.
- STAI – State-Trait Anxiety Inventory – [22]. The STAI
measures a person's situational (or state) anxiety, as well
as the amount of anxiety a person generally feels most of
the time (trait). The two scales contain 20 items each,
which may be scored 1 (not at all) to 4 (very much so).
Immediately before and after each treatment session sub-
jects will be also asked to rate their levels of subjective anx-
iety on the Visual Anxiety Scale (VAS-A). In order to verify
if there is a positive correlation between the treatment effi-
cacy and the sense of presence experienced by the patients
during the treatment sessions, the Itc-Sense of Presence
Inventory (ITC-SOPI) [23] will be administered to each
patient exposed to the VR environment after each session.
The ITC-SOPI is a questionnaire composed by 44 items,
that investigates the sense of presence experienced during
the VR exposure.
Moreover, as homework, patients will be asked to fill
some forms regarding their relaxing experiences.
Psychophysiological assessment
Immediately before and after each treatment session, psy-
chophysiological parameters (skin conductance response
(SCR), muscle tension, heart and respiratory rates) will be
recorded in order to obtain objective measures of the
emotional state of patients. Data will be recorded using
the Procomp Infiniti Biofeedback system. The Procomp
Infiniti System is an 8 channel, multi-modality encoder
used to record different physiological parameters. Con-
nected via USB to the computer, it records 8 parameters in
real time and send them to the PC through fiber optic
cables. In particular, in this study we are interested in
recording 4 parameters: muscle tension, heart rate, respi-
ration and skin conductance, using the following sensors:
• Electromyography sensor – EMG
The electromyography sensor, placed on the surface of the
skin, directly above the forearm's muscles, detects small
electrical current or signals that comes from active mus-
cles registering the muscle tension.
• Blood Volume Pulse sensor – BVP
The BVP is a pulse detection sensor housed in a small fin-
ger worn package, to measure pulse rate of subject. The
BVP sensor uses photoplethysmography to detect the
blood pressure in the extremities. Photoplethysmography
is a process of applying a light source and measuring the
light reflected by the skin. At each contraction of the heart,
blood is forced through the peripheral vessels, producing
engorgement of the vessels under the light source, thereby
modifying the amount of light to the photosensor. The
resulting pressure waveform is recorded.
• Respiration sensor
The Respiration sensor is an easy fitting high durability
latex rubber band fixed with velcro belt for monitoring
respiration rate from a subject. The sensor is strapped to
the torso to measure the relative amount of expansion
that occurs during respiration (breathing). As breathing in
takes place the rib cage expands which stretches the
device. When exhaling, the stretch relaxes and the sensor
returns to its neutral position. The resulting waveform is
displayed on the screen.
• Skin Conductance Response sensors – SCR
The Skin Conductance Response is a measure of the skin's
conductance between two electrodes. Electrodes are small
metal plates that apply a safe, imperceptibly tiny voltage
across the skin. They are typically attached to the subject's
fingers or toes using electrode cuffs or to any part of the
body using a silver-Chloride electrode patch. To measure
the resistance, a small voltage is applied to the skin and
the skin's current conduction is measured. Skin conduct-
ance is considered to be a function of the sweat gland
activity and the skin's pore size. An individual's baseline
skin conductance varies for many reasons, including gen-
der, diet, skin type and situation. Sweat gland activity is
controlled in part by the sympathetic nervous system.
When a subject is startled or experiences anxiety, there will
be a fast increase in the skin's conductance (a period of
seconds) due to increased activity in the sweat glands
(unless the glands are saturated with sweat). After a startle,
the skin's conductance will decrease naturally due to rea-
bsorption. There is a saturation to the effect: when the
duct of the sweat gland fills there is no longer a possibility
of further increasing skin conductance. Excess sweat pours
out of the duct. Sweat gland activity increases the skin's
capacity to conduct the current passing through it and
changes in the skin conductance reflect changes in the
level of arousal in the sympathetic nervous system (see fig-
ure 1).
Data collection
Epidemiological, clinical and all outcome data from each
patient will be recorded by the clinician responsible of the
study in an electronic database. Psychophysiological data
from the Procomp Infinity System will be transformed
and recorded in Excel files.
At the end of the treatment, clinicians will arrange a 6 and
12-month review appointment with the patients in the
intervention groups and a 12-month review for those in
the WL group. At those points clinical follow up data will
be collected. A reminder of forthcoming appointmentsTrials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
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will be distributed to each participant practice 2 weeks
before the appointment is due.
Experimental design
Patients included in the study will be randomly assigned
to one of the following three conditions:
(I) VR: subjects will be taught to relax using VR relaxing
environments and audio-visual mobile narratives;
(II) non-VR: patients will be taught to relax using the same
relaxing narratives proposed to the VR group, but without
the VR support;
(III) WL: patients included in the waiting list group will
not receive any kind of relaxation training.
Psychometric and psychophysiological outcomes will
serve as quantitative dependent variables, while subjective
reports of participants will be used as qualitative depend-
ent variables.
Randomization
The present trial is a randomized controlled trial. Patients
will be randomly assigned to one of the three groups of
treatment using numbers generated at random [24].
Hardware
The VR system is composed by (see figure 2):
- a laptop (Asus G2S; Intel® Core™2 Extreme Processor
X7800);
- an Head Mounted Display (HMD), Sony Glasstron PLM
S-700, equipped with a visual device for a 3D view of the
virtual environment and an audio device (earphones) to
listen to the narratives;
- a position tracker, Intersense Intertrax2 256 Hz, that
allows the user to modify his/her point of view in the vir-
tual environment according to his/her movements in the
real world;
- a joystick.
The iRiver Clix, a portable audio-visual device, will be
assigned to each patient included in the two experimental
groups, in order to help him/her to practice the relaxation
techniques out of the therapist's office. Patients in the VR
group will use it to play video and sound, while the others
will use it just to listen to the narratives.
The virtual environment software
In the present protocol we will use two different virtual
environments included in the open-source software Neu-
roVR (version 1.5) [25].
For the relaxation sessions, the Green Valley, a very relax-
ing environment showing a mountain landscape around
a calm lake is presented together with the relaxing narra-
tive and soft sounds (birds' songs, water flowing, etc) (see
figure 3). Patients are asked to walk around the lake, to
observe the nature and, after few minutes, to virtually seat
on a comfortable deck chair, in order to become easily
relaxed.
For the second part of the protocol, patients will be pre-
sented with specific stressful virtual environments that
simulate real-life situations: a crowded place, a classroom,
an apartment, and so on (see figure 4). Each of these envi-
ronments can be modified by the therapist with objects,
persons and multimedial components depending on the
patients' needs.
Clinical protocol
The clinical protocol will be based on 7 weeks of Applied
Relaxation (AR) training (2 sessions per week). Patients
will be taught coping skills which enable them to relax
rapidly, in order to counteract and possibly eliminate the
anxiety reactions.
We will now describe the protocol in details, following
the one developed by Ost in 1987 [26]. The sessions will
be the same for both groups (VR and non-VR), with the
only difference that the VR group is presented with audio
narratives accompanied by virtual relaxing environments,
while the non-VR group only hear the narratives.
The Procomp Infiniti System Figure 1
The Procomp Infiniti System. a) the Procomp Infiniti 
control box; b) the Skin Conductance Response sensors; c) 
the Electromyography sensor; d) the Blood Volume Pulse 
sensor; e) the Respiration sensor.Trials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
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The protocol will follow the following schema:
- Session one: the therapist clearly explains the patient the
role of bodily arousal in the maintenance of anxiety and
underlines the fact that relaxation procedures can be use-
ful to reduce the autonomic arousal. A general description
of the method used in the following sessions will be given
to the patient. After an oral presentation, patients will
receive a short written description of the rationale. In this
way, they will have the possibility to read the text as many
times as they want, to ask questions about unclear points
and to study it at home.
The following is an example of the text given to the
patients (adapted from Ost, 1987):
"When a person suffers from an excessive anxiety usually man-
ifests three different components in his/her reaction: physiolog-
ical (increased heart rate, blood pressure, sweating etc.),
behavioral (trying to escape from the anxious situation, trem-
bling etc.), and subjective (negative thoughts like 'I am going
to faint or lose control' etc.). The strength of these components
varies between patients, but previous research has found that
most people experience some physiological changes, followed by
a negative thought, which increases the physiological reaction,
generating a vicious circle.
One good way of breaking this development is to focus on the
physiological reactions and learn not to react so strongly. The
method we are going to use to achieve this is called applied
relaxation. The aim of this technique is to learn a skill of relax-
ation, which can be applied very rapidly and in any real-life sit-
uation. This skill can be compared to any other skill, e.g.
learning to swim, ride a bike, or drive a car, in that it takes time
and practice to be learned, but once you have mastered it, you
can use it anywhere. You are not restricted to the calm and non-
stressful situation in the therapist office or your own home.
The goal of the treatment is to be able to relax in few sessions
and to use this skill to counteract, and eventually get rid of, the
physiological reactions you usually experience in anxious situa-
tions. To achieve this we are going through a gradual process
starting with tensing and relaxing different muscle groups.
The next step teaches you to connect the self-instruction 'Relax'
to the bodily state of relaxation. After that it is time for the rapid
relaxation, which you practice many times a day in non-stress-
ful situations. Finally, you reach the stage of applying the skill
in anxious situations, and I will take you to different anxiety-
arousing situations coaching you how to apply the relaxation at
the first signs of anxiety in these situations. Applied relaxation
A screenshot from NeuroVR (V. 1.5) Figure 4
A screenshot from NeuroVR (V. 1.5). The figure illus-
trates a virtual kitchen, one of the stressful environments 
showed to the patients during the last week of treatment.
A screenshot from NeuroVR (V. 1.5) Figure 3
A screenshot from NeuroVR (V. 1.5). The Green Valley 
is the virtual environment used to facilitate relaxation in the 
VR group.
The virtual reality equipment Figure 2
The virtual reality equipment. a) the Head Mounted Dis-
play, Sony Glasstron PLM S-700; 
b) the position tracker, Intersense Intertrax2 256 Hz.Trials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
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is thus a skill that most people can acquire with the right
instructions and practice. It is a 'portable' skill that can be used
in almost any situation, e.g. when having problems in falling
asleep.
During the entire protocol you'll be guided by relaxing narra-
tives (and images) that suggest you how to reach a relaxed
state".
The second part of the session one will be dedicated to fill
the following questionnaires: PSWQ, BAI, AnTi, CID and
STAI.
The following sessions will be dedicated to teach patients
to recognize early signals of nervousness and to cope with
anxiety. Each session lasts about one hour and is divided
in four parts: homework checking, relaxation, comments
about the experience (debriefing) and new homework
assignments. Immediately before and after the relaxation
phase physiological and psychometric measures will be
taken in order to measure the objective and subjective
effects of relaxation on the patient. The relaxation setting
consists in a very quite room scarcely enlighten in which
the patient sits in a comfortable armchair.
Sessions 2–5: during these sessions different narratives
[27,28] guide patients in muscle relaxation. Using the
"Emotioneering" approach [29], in the VR group the
relaxing narrative will be linked to the presentation of the
Green Valley.
Sessions 6–9: in these sessions the focus is on the breath-
ing other than on the muscle relaxation. Again, in the VR
group, the relaxing narrative will be linked to the presen-
tation of the Green Valley.
Sessions 10–13: after nine sessions and weeks of home-
work practice, patients are ready to start applying the
relaxation skill in stressful situations. During these last
sessions a gradual exposure to feared situations is intro-
duced so that patients can practice their applied relaxation
skills. The exposure will be different for the two experi-
mental groups. The VR group will be presented a virtual
environment representing one of the situation that most
frequently elicits anxiety in the patient, while patients in
the non-VR group will use imaginal exposure to imagine
real-life situations that usually provoke high level of anx-
iety.
Session 14: this session is devoted to the final debriefing.
The patient and the therapist discuss about the results
obtained with relaxation. Patients are encouraged to
develop the habit of practice relaxation at least once a day.
They are also encouraged to record their continued prac-
tice on a specific form during the first 6 months after the
end of the treatment and to mail it regularly to the thera-
pist.
During the entire treatment, patients are given different
kind of homework assignments useful to increase their
awareness during the every-day life and not only in the
therapist's office. The first assignment consists in self-
observation: patients are asked to record their anxiety
reactions and to recognize and describe each situation
that provokes them. In particular, between the sessions 2
and 5 patients are asked to fill a form including only Date,
Situation and Intensity of the anxiety reaction (see figure
5). Between the sessions 6 and 9 they also have to fill a
column called "Reaction" (that means: What did you
fell?) and between the sessions 10 and 13 another column
called "Action" (What did you do?) will be also included.
The second assignment consists in practicing relaxation at
least once a day using the portable audio-visual device
they have received from the therapist. Every time they
practice relaxation, they are asked to fill another form reg-
istering at what time they have practiced, how relaxed they
were before and after the practice, how long it took them
and eventually which difficulties they have experienced
(see figure 6).
Follow up assessment
Six and twelve-month follow-up are planned in order to
verify the efficacy of the treatment over a long term
period.
Potential benefit of VR
The use of VR will be introduced with a goal of increasing
the subjects' ability to relax themselves easier than they do
using the traditional relaxing methods. If analyses find
that the use of VR improves the relaxation processes and
the reduction of anxiety, then a range of benefits are pos-
sible. For example, satisfactory ability to manage the
patient's anxiety could be increased and length of treat-
ment could be reduced.
Potential harms of VR
Potential for harms is minimal. The only risk really asso-
ciated with the use of VR is the so-called cybersickness,
Form of self-observation of early anxiety signals (adapted  from Ost, 1987) Figure 5
Form of self-observation of early anxiety signals 
(adapted from Ost, 1987).
Date Situation Intensity Reaction (What did you feel?) Action (What did you do?)
        
        
        
        Trials 2008, 9:25 http://www.trialsjournal.com/content/9/1/25
Page 8 of 9
(page number not for citation purposes)
that is characterized by symptoms that parallel those of
classical motion sickness both during and after the virtual
experience. Cybersickness is rare and sometimes disap-
pears after few minutes of rest.
Trial analysis
Data will be entered in SPSS. Descriptive methods will be
used to demonstrate the consistency of the three groups,
describe participant characteristics and report levels of
participation and drop out. Analysis of variance will be
used to evaluate baseline characteristics of the three
groups involved in the study, overall significance of
improvement across outcome measures, and drop out ver-
sus maintainers. For each patient, change in psychometric
and physiological measures will be calculated and ana-
lysed using t-test for matched groups for both interven-
tion and control groups. The magnitude of change will be
estimated and the 95% confidence intervals given.
Discussion
Despite a large number of studies showing the advantages
of using VR for the treatment of anxiety disorders (for a
recent review see [30]), up to date there is only one study
about its potential in stress management and relaxation
processes in a sample of non-clinical stressed subjects
[15]. What we would like to show with the present study
is that VR can facilitate the reduction of anxiety even in a
sample of GAD patients. We believe that the use of
immersive VR for relaxation represents a promising
approach since it enhances the quality of the relaxing
experience through the elicitation of the sense of presence.
In fact, as reported by different studies [31-34], individu-
als who interact in environments enriched with a variety
of positive visual and auditory stimulations, report greater
improvement in self-efficacy and mood. Being able to
become relaxed in a certain situation promotes the sense
of self-efficacy and prepares participants to cope with real
anxiety situations.
Our outcome measures are well-suited to measuring both
the subjective and objective impact related to the inter-
vention and the presence of a non-VR group and of a WL
list group will guarantee that the results eventually found
are really attributable to the intervention. This controlled
trial will be able to evaluate the effects of the use of VR in
relaxation while preserving the benefits of randomization
to reduce bias. Its design takes into account the need for
internal and external validity and that the results are
attributable to the intervention. Since the international
scientific community is now starting to widely recognize
the potential of VR as clinical tool [35] we look forward to
adding the results of this trial to the growing body of liter-
ature in this area.
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